A collaborative effort among international research teams provides the most definitive statement yet on the usefulness of ...
A large Scandinavian study reopens the debate on beta-blockers after myocardial infarction, revealing selective benefits.
Please provide your email address to receive an email when new articles are posted on . Patients who received beta-blocker therapy reported higher anxiety, more frequent depressed mood and worse ...
In a recent study published in The New England Journal of Medicine, researchers conducted the Randomized Evaluation of Decreased Usage of Beta-Blockers after Acute Myocardial Infarction (REDUCE-AMI) ...
Madrid, Spain – 30 August 2025 : Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no ...
Madrid, Spain – 30 August 2025: Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality and major adverse cardiovascular events compared with no beta-blocker therapy in ...
Beta-blockers provide no clinical benefit to post-MI patients with preserved left ventricular ejection fraction, according to a potentially paradigm-changing meta-analysis. The findings, published ...
Please provide your email address to receive an email when new articles are posted on . Beta-blocker therapy did not improve survival beyond 1 year after an MI, although a dose-dependent effect was ...
Credit: Getty Images. A discussion of the use of beta-blocker therapy following AMI, with Christopher Granger, MD, Gregg Fonarow, MD, and Carlin S Long, MD. The role of beta-blockers after acute ...
Hosted on MSN
Beta blockers reduce mortality and heart failure in MI patients with mildly reduced ejection fraction
Beta-blocker therapy significantly reduced a composite endpoint of all-cause mortality, new myocardial infarction (MI) and heart failure (HF) compared with no beta-blocker therapy in the subgroup of ...
(HealthDay News) — For patients with ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI), beta-blocker therapy at discharge correlates with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback